Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major ...
Clinical conduct of both blarcamesine (ANAVEX®2-73) studies in healthy volunteers is now complete, data are expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results